3'-amino-2',3'-dideoxyuridine has been researched along with carmustine in 1 studies
*Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed) [MeSH]
*Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed) [MeSH]
Studies (3'-amino-2',3'-dideoxyuridine) | Trials (3'-amino-2',3'-dideoxyuridine) | Recent Studies (post-2010) (3'-amino-2',3'-dideoxyuridine) | Studies (carmustine) | Trials (carmustine) | Recent Studies (post-2010) (carmustine) |
---|---|---|---|---|---|
6 | 0 | 0 | 4,168 | 686 | 540 |
Protein | Taxonomy | 3'-amino-2',3'-dideoxyuridine (IC50) | carmustine (IC50) |
---|---|---|---|
Glutathione reductase, mitochondrial | Homo sapiens (human) | 8.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brubaker, WF; Lin, TS; Park, S; Prusoff, WH; Wang, ZH | 1 |
1 other study(ies) available for 3'-amino-2',3'-dideoxyuridine and carmustine
Article | Year |
---|---|
Antineoplastic activity of 3'-(chloroethyl)nitrosourea analogues of 2'-deoxyuridine and 2'-deoxy-5-fluorouridine.
Topics: Alkylation; Animals; Antineoplastic Agents; Deoxyuridine; Dideoxynucleosides; Female; Floxuridine; Leukemia L1210; Mice; Nitrosourea Compounds; Structure-Activity Relationship | 1986 |